Heme oxygenase‐1 (HO‐1) inhibits postmyocardial infarct remodeling and restores ventricular function
Open Access
- 1 February 2006
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 20 (2) , 207-216
- https://doi.org/10.1096/fj.05-4435com
Abstract
We reported previously that predelivery of the anti-oxidant gene heme oxygenase-1 (HO-1) to the heart by adeno associated virus (AAV) markedly reduces injury after acute myocardial infarction (MI). However, the effect of HO-1 gene delivery on postinfarction recovery has not been investigated. In the current study, we assessed the effect of HO-1 gene delivery on post-MI left ventricle (LV) remodeling and function using echocardiographic imaging and histomorphometric approaches. Two groups of Sprague-Dawley rats were injected with 4 × 1011 particles of AAV-LacZ (control) or AAV-hHO-1 in the LV wall. Eight wk after gene transfer, the animals were subjected to 30 min of ischemia by ligation of left anterior descending artery (LAD) followed by reperfusion. Echocardiographic measurements were obtained in a blinded fashion prior and at 1.5 and 3 months after I/R. Ejection fraction (EF) was reduced by 13% and 40% in the HO-1 and LacZ groups, respectively at 1.5 months after MI. Three months after MI, EF recovered fully in the HO-1, but only partially in the LacZ-treated animals. Post-MI LV dimensions were markedly increased and the anterior wall was markedly thinned in the LacZtreated animals compared with the HO-1-treated animals. Significant myocardial scarring and fibrosis were observed in the LacZ-group in association with elevated levels of interstitial collagen I and III and MMP-2 activity. Post-MI myofibroblast accumulation was reduced in the HO-1-treated animals, and retroviral over-expression of HO-1 reduced proliferation of isolated cardiac fibroblasts. Our data indicate that rAAV-HO-1 gene transfer markedly reduces fibrosis and ventricular remodeling and restores LV function and chamber dimensions after myocardial infarction.—Liu, X., Pachori, A. S., Ward, C. A., Davis, J. P., Gnecchi, M., Kong, D., Zhang, L., Murduck, J., Yet, S.-F., Perrella, M. A., Pratt, R. E., Dzau, V. J., Melo, L. G. Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function. FASEB J. 20, 207–216 (2006)Keywords
Funding Information
- Canadian Institutes of Health Research
- National Institutes of Health (HL 35610, HL 05316, HL 072010, HL 073219)
This publication has 25 references indexed in Scilit:
- Inflammatory Cytokines and Postmyocardial Infarction RemodelingCirculation Research, 2004
- Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivoAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Pre-emptive gene therapy using recombinant adeno-associated virus delivery of extracellular superoxide dismutase protects heart against ischemic reperfusion injury, improves ventricular function and prolongs survivalGene Therapy, 2004
- Myofibroblast and Endothelial Cell Proliferation during Murine Myocardial Infarct RepairThe American Journal of Pathology, 2003
- Ventricular Remodeling After Infarction and the Extracellular Collagen MatrixCirculation, 2003
- Different Faces of the Heme-Heme Oxygenase System in InflammationPharmacological Reviews, 2003
- Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null miceJournal of Clinical Investigation, 1999
- Superoxide induces apoptosis in cardiomyocytes, but proliferation and expression of transforming growth factor‐β1 in cardiac fibroblastsFEBS Letters, 1999
- Induction of the Haem Oxygenase Gene Expression during the Reperfusion of Ischemic Rat MyocardiumJournal of Molecular and Cellular Cardiology, 1996
- Bilirubin Is an Antioxidant of Possible Physiological ImportanceScience, 1987